the importance of metex14 testing in nsclc
Published 2 years ago • 101 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
2:49
the challenges of treating metex14 nsclc
-
0:43
geometry study confirms importance of testing for metex14 alteration in advanced nsclc
-
13:00
recognizing the role of capmatinib for metex14 in nsclc
-
6:13
vision: tepotinib in met exon 14 skipping nsclc
-
3:05
tepotinib in metex14 skipping alteration nsclc
-
1:18
amivantamab for nsclc with met exon 14 skipping mutations
-
3:40
metex14 sas (met exon 14 skipping alterations) in non-small cell lung cancer
-
8:04
fda priority review of capmatinib for metex14-mutated nsclc
-
1:02
investigating met exon 14 mutations in patients with nsclc
-
1:25
dr. wolf on updated findings with capmatinib in metex14-mutant nsclc
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
1:54
dr. le on the rationale for tepotinib in metex14-mutant nsclc
-
4:18
when should biomarker testing be done in nsclc?
-
0:58
challenges and treatment of cns metastases in nsclc
-
1:37
ngs for the detection of mutations in nsclc
-
3:24
off-label crizotinib for the treatment of metex14-mutated nsclc
-
6:43
molecular testing in patients with metastatic nsclc
-
55:31
the future of tumor testing
-
9:23
mutation testing for all patients with nsclc